LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
26.72
-1.18 (-4.23%)
At close: Dec 5, 2025, 4:00 PM EST
26.71
-0.01 (-0.04%)
After-hours: Dec 5, 2025, 7:56 PM EST
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $836.07 million as of December 5, 2025. Its market cap has decreased by -12.26% in one year.
Market Cap
836.07M
Enterprise Value
634.85M
1-Year Change
-12.26%
Ranking
Category
Stock Price
$26.72
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has increased from $413.64M to $836.07M, an increase of 102.12%. That is a compound annual growth rate of 51.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 836.07M | 5.30% |
| Dec 31, 2024 | 793.95M | 91.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |